ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,896.98
      0.45%
      US Tech 100
      20,084.00
      1.11%
      Dow Jones
      43,443.12
      0.00%
      Brent Oil
      72.845
      3.03%
      Bitcoin
      91,522.22
      1.84%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Crossject (ALCJ) Quote

      Crossject

      Crossject (ALCJ)

      EU
      1.974
      -0.061
      (-3.00%)
      Closed November 18 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.974
      Bid
      1.96
      Ask
      1.98
      Volume
      52,763
      1.922 Day's Range 2.03
      1.52 52 Week Range 5.96
      Market Cap
      72.571M
      Previous Close
      2.035
      Open
      2.03
      Last Trade
      76
      @
      1.974
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      73,210
      Shares Outstanding
      36,763,256
      Dividend Yield
      -
      PE Ratio
      -8.43
      Earnings Per Share (EPS)
      -0.24
      Revenue
      9.14M
      Net Profit
      -8.64M

      About Crossject

      Sector
      Med, Dental, Hosp Eq-whsl
      Industry
      Med, Dental, Hosp Eq-whsl
      Website
      www.crossject.com
      Headquarters
      Dijon, Cote-d'or, Fra
      Founded
      -
      Crossject is listed in the Med, Dental, Hosp Eq-whsl sector of the Euronext with ticker ALCJ. The last closing price for Crossject was 2.04 €. Over the last year, Crossject shares have traded in a share price range of 1.52 € to 5.96 €.

      Crossject currently has 36,763,256 shares outstanding. The market capitalization of Crossject is 74.81 € million. Crossject has a price to earnings ratio (PE ratio) of -8.43.

      Ask ADVFN Intelligence (AI)

      ALCJ Latest News

      More News

      FeaturedNorth Bay Resources Announces Production of Gold Concentrate and Refinery Shipment at Bishop Gold Mill, California

      3 hours ago

      Crossject démontre à nouveau la facilité d’utilisation de son auto-injecteur ZENEO® dans une nouvelle étude en conditions extrêmes

      Crossject démontre à nouveau la facilité d’utilisation de son auto-injecteur ZENEO® dans une nouvelle étude en conditions extrêmes   Crossject achève avec succès une nouvelle étude américaine de...

      November 13 2024
      UK Regulatory

      Crossject’s ZENEO® Auto-Injector's usability further demonstrated in extreme HAZMAT conditions

      Crossject’s ZENEO® Auto-Injector's usability further demonstrated in extreme HAZMAT conditions Crossject successfully completes a new U.S. summative human factors study to assess the...

      November 13 2024
      UK Regulatory

      Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization

      Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization Product batch announced in July yielded new regulatory...

      October 22 2024
      UK Regulatory

      Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization

      Product batch announced in July yielded new regulatory stability data. These results will directly support the requested 6-month stability data in the first quarter of 2025Crossject expects to...

      October 22 2024
      GlobeNewswire Inc.

      Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

      Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information relative au nombre total de droits de vote et...

      October 07 2024
      UK Regulatory

      Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

      Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information relative au nombre total de droits de vote et...

      October 07 2024
      UK Regulatory

      Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

      Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information relative au nombre total de droits de vote et...

      October 07 2024
      UK Regulatory

      Crossject annonce son éligibilité au dispositif d’investissement PEA-PME

      Crossject annonce son éligibilité au dispositif d’investissement PEA-PME Le PEA-PME permet aux investisseurs particuliers français d'acheter des titres à des conditions fiscales préférentielles...

      September 26 2024
      UK Regulatory

      Crossject announces its eligibility for France’s PEA-PME investment scheme

      Crossject announces its eligibility for France’s PEA-PME investment scheme Enables French retail investors to buy securities under preferential tax conditions Dijon, France Sept 26, 2024...

      September 26 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.126-62.12.1851.922591432.10085756DE
      4-0.676-25.50943396232.652.751.85999032.21951121DE
      12-0.356-15.27896995712.332.751.85732102.28473516DE
      26-0.006-0.303030303031.982.751.52745842.07563832DE
      52-2.421-55.08532423214.3955.961.52865843.03446422DE
      156-0.956-32.62798634812.935.961.408842433.29662976DE
      260-1.096-35.70032573293.075.961.041308103.03061976DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MHMMyHotelMatch
      0.598 €
      (71.84%)
      		72.21k
      CNVCnova NV
      1.125 €
      (60.71%)
      		14.78k
      EMGDSEuromedis DS
      0.015 €
      (36.36%)
      		11.96k
      MLNMAMiguet Et Associes
      0.0995 €
      (24.38%)
      		650
      EBUSEbusco Holding NV
      1.51 €
      (19.27%)
      		943.58k
      EBUSREbusco
      0.0003 €
      (-99.81%)
      		6.18M
      MLONEBody One
      0.24 €
      (-25.00%)
      		3.18k
      ALSPWSpineway
      0.1066 €
      (-18.00%)
      		2.22M
      HYLHyloris Pharmaceuticals SA
      3.30 €
      (-17.50%)
      		51k
      ALVERVergnet
      0.0049 €
      (-15.52%)
      		9.6M
      ALNEVNeovacs
      0.0002 €
      (0.00%)
      		43.54M
      BCPBanco Comercial Portugues SA
      0.4476 €
      (0.65%)
      		24.84M
      ALHPIHopium SA
      0.0098 €
      (-2.00%)
      		19.79M
      ALCYBCybergun
      0.0001 €
      (0.00%)
      		12.96M
      ALVERVergnet
      0.0049 €
      (-15.52%)
      		9.6M

      Discussion

      View Full Feed
      TucsonPhil TucsonPhil 2 minutes ago
      Fidelity reporting 32.55% short in this stock. Given recent news, it is ripe for a squeeze.
      EVGO
      badgerkid badgerkid 2 minutes ago
      New to IOVA and Iovance? Here's some source material to get you started:

      The Iovance corporate presentation: https://ir.iovance.com/static-files/f81194ff-6f65-4ed4-af92-67362eb17901

      Iovance is a fast growing company with a lot of career opportunities: https://www.iovan
      IOVA
      MegaPirate61 MegaPirate61 2 minutes ago
      Especially if soc in asthma and label expansion seasonal allergies... then it's worth is really high for that spring pollen pop. If international then it will be a bicyclical which would smooth the revenue curve. Lots of if statements of course.
      VRNA
      Acme Investments Acme Investments 2 minutes ago
      Are you happy about being half way from where you were?? Knock it off!! If you get back there let me know!! Later Yungdum I'm busy!!
      HIRU
      aBeezlee aBeezlee 3 minutes ago
      Maybe a reaction to their participation at upcoming conferences? Could be another volatile week for space.
      ASTS
      dinogreeves dinogreeves 3 minutes ago
      I don't this this was the one I saw on the link below, but yes, I might have gotten confused with lobbying part vs donating to the campaign

      https://www.opensecrets.org/federal-lobbying/clients/summary?cycle=2024&id=D000108919


      I believe I saw something similar to
      TGLO
      jxyzobrien jxyzobrien 3 minutes ago
      es

      https://investorshub.advfn.com/uimage/uploads/2024/11/18/ofgxospx18.png
      MRc2 MRc2 3 minutes ago
      $ILLR~ Software Architect. eom
      ILLR
      Konaploinks Konaploinks 3 minutes ago
      Let’s hear how it’s all going Peter. A little update would be nice!
      IONQ
      MasterBlastr MasterBlastr 3 minutes ago
      Lots of players dealing with injuries that are catching up with them as the season moves on. Lamar is one of them.
      sharkey1 sharkey1 3 minutes ago
      the big boys are milking it, taking every ounce they can, on the news,
      it's obvious

      we are at bay
      ELTP
      CHILLWILL1704 CHILLWILL1704 4 minutes ago
      Have faith and leave it to God---He understands our problems and suffering--God Bless
      MVNT
      Shonnieville Shonnieville 4 minutes ago
      Oh wow, you actually received a reply?!?!

      That's good if someone responded.
      FONU
      Buckey Buckey 4 minutes ago
      Certainly any aging of the steak can greatly add to the flavour but also the price as mass is lost during that process. I think its the dry aging that looks kind of disgusting but the end result is fabulous
      Bountiful_Harvest Bountiful_Harvest 4 minutes ago
      Trump Officials Reportedly Easing Rules For Self-Driving Cars As Elon Musk Pushes Robotaxis

      https://www.zerohedge.com/technology/trump-officials-reportedly-easing-rules-self-driving-cars-elon-musk-pushes-robotaxis

      Just bookmarking this article for myself as it makes som
      TSLA
      1vman 1vman 4 minutes ago
      ***** 🚽HIRU🚽 Heading back to triple zeros zero

      ENOUGH SAID HUZZAH🤪 !!!
      HIRU
      mick mick 4 minutes ago
      180 Life Sciences Corp. (NASDAQ: ATNF)
      Aditxt Inc. (NASDAQ: ADTX)
      Amesite Inc. (NASDAQ: AMST)
      Annovis Bio Inc. (NYSE: ANVS)
      Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF)
      Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)
      Astiva Health
      Aston
      ADTX AMC ANVS
      Beerworld Beerworld 5 minutes ago
      Bot SPY 587 P @091 11/19
      Amigo Mike Amigo Mike 5 minutes ago
      As often happens,

      Large offer puts the brakes on rally and shows it to market .... LOL. Then others step in front of it to sell cause largest order gets the action for same price ... large offer don't get hit ....... large offer persists and tired of waiting ..... large offer lowers
      SMH ZIVO
      tmcfo tmcfo 5 minutes ago
      Listen, I feel your pain as much as you do too, just trying to be a bit positive that things will turn out positive for shareholders. We all feel that company has let shareholders down but we still have some hope for redemption from mvnt.
      MVNT
      iamthe walrus iamthe walrus 5 minutes ago
      Revenue dropped drastically in one year
      statement of comprehensive income [abstract]

      2024-07-01 ~ 2024-09-30 2024-01-01 ~ 2024-09-30 2023-07-01 ~ 2023-09-30 2023-01-01 ~ 2023-09-30

      Revenue 35,949,920,212 99,765,653,769 31,027,084,559 96,445,205,062
      CRTG
      TucsonPhil TucsonPhil 5 minutes ago
      A well reasoned response.

      I believe the U.S. will increase oil production and net exports under the new administration. That should initially drive fuel prices down, until it forces the OPEC+ nations to restrict supply, in an attempt to drive prices back up.

      Tensions wi
      LCID
      drink-up drink-up 6 minutes ago
      He is still tweeting about it. Boy these promoters sure are pathetic human beings.
      APRU
      Juancy Juancy 6 minutes ago
      The idea is to make money. Boasting or bragging about predictions is irrelevant.
      BTCUSD

      Your Recent History

      EU
      ALCJ
      Crossject
      Delayed Upgrade Clock